ARIJIV MD 15 TAB

About

Aripiprazole, presented as ARIJIV MD 15 TAB, is an atypical antipsychotic medication primarily indicated for the treatment of schizophrenia, bipolar I disorder (manic or mixed episodes), and as an adjunctive therapy for major depressive disorder. It operates as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and an antagonist at serotonin 5-HT2A receptors, thereby helping to rebalance neurotransmitter activity in the brain. This unique pharmacological profile contributes to its efficacy in managing psychotic symptoms, stabilizing mood fluctuations, and improving thought processes. Its mechanism aims to minimize certain extrapyramidal side effects commonly associated with older antipsychotics, offering a broader therapeutic window for patients requiring long-term psychiatric management.

Uses

• Treatment of schizophrenia.
• Management of bipolar I disorder (manic/mixed episodes).
• Adjunctive treatment for major depressive disorder.
• Irritability associated with autistic disorder.

Directions For Use

Take orally once daily, with or without food, as prescribed by your healthcare provider. The MD tablet may dissolve in the mouth.

Benefits

• Reduces psychotic symptoms.
• Stabilizes mood in bipolar disorder.
• Enhances antidepressant effects.
• Improves thought organization.
• Helps manage agitation.
• May improve social functioning.

Side Effects

• Nausea and vomiting
• Constipation
• Headache
• Dizziness
• Akathisia (restlessness)
• Insomnia
• Anxiety
• Weight gain
• Blurred vision
• Tremor
• Sedation
• Orthostatic hypotension

Safety Measures

• Alcohol - Avoid alcohol as it can intensify central nervous system depression, leading to increased drowsiness and dizziness.
• Pregnancy - Use only if the potential benefit justifies the potential risk to the fetus. Consult your doctor.
• Breastfeeding - Aripiprazole passes into breast milk. Consult your doctor to discuss risks and benefits for the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary.
• Kidney - No dose adjustment is typically required for mild to moderate renal impairment, but caution is advised in severe cases.
• Lung - No specific contraindications related to lung conditions, but monitor for respiratory depression if co-administered with CNS depressants.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.